Treatment Guidelines for Hepatic Encephalopathy

Pharmacotherapy - Tập 30 Số 5P2 - 2010
John R. J. Thompson1
1Department of Pharmacy Practice, Lipscomb University College of Pharmacy, Nashville, Tennessee 37204-3951, USA. [email protected]

Tóm tắt

Practice guidelines for hepatic encephalopathy were developed and published in 2001 for overall management in adults. Hepatic encephalopathy is caused by nitrogenous substances from the gastrointestinal tract that adversely affect brain function. Hepatic encephalopathy is a diagnosis of exclusion. The West Haven criteria are recommended for staging the disease. Treatment goals are providing supportive care, identifying and removing precipitating factors, reducing nitrogenous load, and assessing long‐term therapy needs. Data from some trials published before 2001 are not included in the guidelines. In addition, since the publication of the guidelines, new data have become available regarding treatment interventions and outcomes. Newer, nonabsorbed agents, such as rifaximin, alone or in conjunction with lactulose, may enhance compliance and adherence with therapy, and provide better treatment outcomes. New updated practice guidelines need to be developed for hepatic encephalopathy, along with treatment algorithms for patients with both minimal hepatic encephalopathy and overt hepatic encephalopathy. Key Words: hepatic encephalopathy, practice guidelines, lactulose, rifaximin.

Từ khóa


Tài liệu tham khảo

10.1111/j.1572-0241.2001.03964.x

10.1185/03007999309111539

Massa P., 1993, Treatment of hepatic encephalopathy with rifaximin: double bind, double dummy study versus lactulose, Eur J Clin Res, 4, 7

10.1016/S0011-393X(05)80681-2

10.1185/03007999709113333

10.1055/s-2007-1007236

10.1055/s-2007-1007237

10.1055/s-2007-1007238

10.1016/0006-8993(95)00241-H

Zieve L., 1974, Synergism between mercaptans and ammonia or fatty acids in the production of coma: a possible role for mercaptans in the pathogenesis of hepatic coma, J Lab Clin Med, 83, 16

10.1016/S0016-5085(99)70457-9

10.1016/0013-4694(84)90071-3

10.1007/BF01405862

10.1097/00042737-200012020-00012

10.1016/S0168-8278(85)80745-5

10.1001/archneur.1996.00550080076015

10.1002/hep.510280108

10.1002/hep.510270204

10.3310/hta5160

10.1136/bmj.318.7182.527

10.1136/qshc.4.1.55

10.1016/0140-6736(93)92244-N

Worrall G., 1997, The effects of clinical practice guidelines on patient outcomes in primary care: a systematic review, Can Med Assoc J, 156, 1705

Thomas L., 2000, Guidelines in professions allied to medicine, Cochrane Database Syst Rev, 2

MacLeodFE HarrisonMB GrahamID.The process of developing best practice guidelines for nurses in Ontario: risk assessment and prevention of pressure ulcers. Ostomy wound management. Available fromwww.o‐wm.comarticle903AccessedFebruary 12 2010.

Thông tin
Thông tin xuất bản

Pharmacotherapy

Tập 30 Số 5P2

Thông tin tác giả